Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.MATBIO.2019.01.002 | ||||
| Año | 2019 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Muscular fibrosis is caused by excessive accumulation of extracellular matrix (ECM) that replaces functional tissue, and it is a feature of several myopathies and neuropathies. Knowledge of the biology and regulation of pro-fibrotic factors is critical for the development of new therapeutic strategies. Upon unilateral sciatic nerve transection, we observed accumulation of ECM proteins such as collagen and fibronectin in the denervated hindlimb, together with increased levels of the profibrotic factors transforming growth factor type beta (TGF-beta) and connective tissue growth factor (CTGF/CCN2). In mice hemizygous for CTGF/CCN2 or in mice treated with a blocking antibody against CTGF/CCN2, we observed reduced accumulation of ECM proteins after denervation as compared to control mice, with no changes in fibro/adipogenic progenitors (FAPs), suggesting a direct role of CTGF/CCN2 on denervation-induced fibrosis. During time course experiments, we observed that ECM proteins and CTGF/CCN2 levels are increased early after denervation (2-4 days), while TGF-beta signaling shows a delayed kinetics of appearance (1-2 weeks). Furthermore, blockade of TGF-beta signaling does not decrease fibronectin or CTGF levels after 4 days of denervation. These results suggest that in our model CTGF/CCN2 is not up-regulated by canonical TGF-beta signaling early after denervation and that other factors are likely involved in the early fibrotic response following skeletal muscle denervation. (C) 2019 Elsevier B.V. All rights reserved.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | REBOLLEDO-LOPEZ, DANIELA VICTORIA | Mujer |
CARE Chile UC - Chile
Universidad Bernardo O'Higgins - Chile |
| 2 | Gonzalez, David | Hombre |
CARE Chile UC - Chile
Pontificia Universidad Católica de Chile - Chile Departamento de Biología Celular y Molecular - Chile |
| 3 | Faundez-Contreras, Jennifer | Mujer |
CARE Chile UC - Chile
Pontificia Universidad Católica de Chile - Chile Departamento de Biología Celular y Molecular - Chile |
| 4 | Contreras, Osvaldo | Hombre |
CARE Chile UC - Chile
Pontificia Universidad Católica de Chile - Chile Departamento de Biología Celular y Molecular - Chile |
| 5 | VIO-LAGOS, CARLOS PABLO | Hombre |
CARE Chile UC - Chile
Pontificia Universidad Católica de Chile - Chile |
| 6 | Murphy-Ullrich, Joanne E. | Mujer |
Univ Alabama Birmingham - Estados Unidos
Department of Cell, Developmental and Integrative Biology - Estados Unidos The University of Alabama at Birmingham - Estados Unidos UAB Department of Pathology - Estados Unidos |
| 7 | Lipson, Kenneth E. | Hombre |
FibroGen Inc - Estados Unidos
FibroGen, Inc. - Estados Unidos |
| 8 | BRANDAN-SIQUES, ENRIQUE HECTOR | Hombre |
CARE Chile UC - Chile
Pontificia Universidad Católica de Chile - Chile Departamento de Biología Celular y Molecular - Chile |
| Fuente |
|---|
| FONDECYT |
| CONICYT |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Comisión Nacional de Investigación Científica y Tecnológica |
| Chilean National Council for Science and Technology |
| Consejo Nacional de Innovacion, Ciencia y Tecnologia |
| National Research Council of Science and Technology |
| UC CINBIOT Animal Facility |
| Beca de Doctorado Nacional Folio |
| PIA CONICYT* ECM-07, Program for Associative Research |
| Alabama Drug Discovery Alliance |
| UC CINBIOT |
| E.B.. |
| Agradecimiento |
|---|
| The authors are grateful to Eduardo Ramirez, Darling Vera, Lina Correa and Carlos Cespedes. for technical support. This work was supported by CONICYT AFB170005 and FONDECYT 1150106 to E.B.. FONDECYT Postdoctoral training grant 3140357 and Fondecyt 11181090 to D.L.R.. Beca de Doctorado Nacional Folio 21130854 and 21140378 to D.G. and O. C. respectively. J.E.M-U. was partially supported by funds from the Alabama Drug Discovery Alliance. The authors acknowledge the services provided by UC CINBIOT Animal Facility funded by PIA CONICYT* ECM-07, Program for Associative Research, of the Chilean National Council for Science and Technology. The funding agencies had no role in the design of the study, data collection, and analysis, the decision to publish, or preparation of the manuscript. |
| The authors are grateful to Eduardo Ramirez, Darling Vera, Lina Correa and Carlos Céspedes. for technical support. This work was supported by CONICYT AFB170005 and FONDECYT 1150106 to E.B. FONDECYT Postdoctoral training grant 3140357 and Fondecyt 11181090 to D.L.R. Beca de Doctorado Nacional Folio 21130854 and 21140378 to D.G. and O.C. respectively. J.E.M-U. was partially supported by funds from the Alabama Drug Discovery Alliance. The authors acknowledge the services provided by UC CINBIOT Animal Facility funded by PIA CONICYT* ECM-07, Program for Associative Research, of the Chilean National Council for Science and Technology. The funding agencies had no role in the design of the study, data collection, and analysis, the decision to publish, or preparation of the manuscript. |